Vaccine Ontology
14117 terms(s) returned
| Term Type: Class | Record: 8501 to 8550 of 14117 Records | Page: 171 of 283, First Previous Next Last | Show Records Per Page |
- S. pneumoniae PhpA-79 Protein Vaccine
- S. pneumoniae PiaA Protein Vaccine
- S. pneumoniae PspA Protein Vaccine
- S. pneumoniae RASV synthesizing PsaA
- S. pneumoniae SrtA Protein Vaccine
- S. pneumoniae pspA-rBCG Vector Vaccine
- S. pyogenes Emm1 Protein Vaccine
- S. pyogenes FBP54 Protein Vaccine
- S. pyogenes FbaA Protein Vaccine
- S. pyogenes SfbI Protein Vaccine
- S. pyogenes Sib35 Protein Vaccine
- S. typhi DnaJ Protein Vaccine
- S. typhi GroEL Protein Vaccine
- S. typimurium Vi4072
- SAF-1 vaccine adjuvant
- SAG1 from Sarcocystis neurona
- SAG1 from Toxoplasma gondii
- SARS ADS-MVA vaccine
- SARS Ad S/N vaccine
- SARS CTLA4-S DNA vaccine
- SARS M protein DNA vaccine
- SARS MA-ExoN vaccine
- SARS MVA/S vaccine
- SARS N + SARS M DNA vaccine
- SARS N protein DNA vaccine
- SARS NDV-BC/S vaccine
- SARS NDV-VF/S vaccine
- SARS Subunit Spike Protein Vaccine
- SARS rMA15-ΔE vaccine
- SARS tPA-S DNA vaccine
- SARS vaccine
- SARS-COV-2 (COVID-19) vaccine D614 prefusion spike recombinant protein subunit (CoV2 preS dTM) AS03 adjuvant added preservative free 10mcg/0.5mL dose
- SARS-COV-2 (COVID-19) vaccine D614 prefusion spike recombinant protein subunit (CoV2 preS dTM) AS03 adjuvant added preservative free 5mcg/0.5mL dose
- SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK
- SARS-COV-2 (COVID-19) vaccine UNSPECIFIED
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 10 mcg/0.2 mL dose
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 10 mcg/0.2 mL dose tris-sucrose formulation
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 30 mcg/0.3 mL dose tris-sucrose formulation
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 50 mcg/0.5 mL or 25 mcg/0.25 mL dose
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent preservative free 3 mcg/0.2 mL dose tris-sucrose formulation
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 10 mcg/0.2mL dose tris-sucrose formulation
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 3 mcg/0.2mL dose tris-sucrose formulation
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 30 mcg/0.3mL dose
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 30 mcg/0.3mL dose tris-sucrose formulation
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 50 mcg/0.5 mL dose
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free pediatric 25 mcg/0.25 mL dose
- SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free pediatric 50 mcg/0.5 mL dose
- SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation
- SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose
